OLMESARTAN MEDOXOMIL
NDC 64980-603, olmesartan medoxomil, tablet, coated, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-603
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208659
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-603 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLMESARTAN MEDOXOMIL40 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-603-03 | 64980060303 | 30 TABLET, COATED in 1 BOTTLE (64980-603-03) |
| 64980-603-09 | 64980060309 | 90 TABLET, COATED in 1 BOTTLE (64980-603-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b02ff20e-3f0e-43f4-a7b5-6ce56295d023NADAC price for package 64980060303
GET /v1/drugs/nadac/64980060303NADAC price for package 64980060309
GET /v1/drugs/nadac/64980060309
Use it
Look up 64980-603 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-603 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-603. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.